Search results
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Given Consensus Recommendation of “Buy” by Analysts
ETF DAILY NEWS· 4 days agoShares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Free Report) have received a consensus recommendation of “Buy” from the twelve analysts that are covering the stock, Marketbeat reports.
ELYSEE Earns $278,436 ($0.01 per Share) During the Three Months Ended March 31, 2024
StreetInsider· 3 days ago(TSXV: ELC) (FSE: QLDN) is pleased to announce its unaudited financial results for the three months ended March 31, 2024 ("Q1 2024"). During the first three months of 2024 Elysee's investment ...